Fewer and fewer women die from breast cancer in recent years but, surprisingly, the decline is just as large in the age groups that are not screened. The decline is therefore due to better treatment and not screening for breast cancer.
Calif. Gov. Jerry Brown’s signature this week on Dense Breast Tissue Awareness bill (SB-1034) means the requirement to notify California women about breast density will continue uninterrupted through January 1, 2025.
Columbus Regional Health (Columbus, Ind.) has deployed a Carestream DRX-Transportable System/Lite to complete its conversion to DR. The DRX-Transportable System/Lite includes a wireless DRX Plus 3543 detector, wireless access point and tablet PC. It is used in two fluoroscopy rooms and a general exam room that has fixed detectors.
In February 2018, a workshop was held at the National Institutes of Health (NIH) in Bethesda, Maryland, to explore concerns about the safety of gadolinium-based contrast agents (GBCAs) and gadolinium retention. The workshop was co-sponsored by NIH, the Radiological Society of North America (RSNA) and the American College of Radiology (ACR).
Client Outlook, a leading provider of FDA Class II enterprise diagnostic and clinical image viewing solutions, announced its partnership with DocPanel Technologies to support a progressive alternative to traditional radiology reading services.
UCLA researchers have discovered that a combination of high doses of radiotherapy and hormonal therapy provides the best chance of decreasing the mortality rate in men with aggressive prostate cancer. The findings also suggest that such a multimodal treatment approach has the best chance of preventing metastatic disease and improving overall long-term survival.
Shimadzu Corp. has entered the medical near-infrared camera market with the release of the Lightvision near-infrared fluorescence imaging system. The new Lightvision is designed to support breast cancer treatment through the visualization of lymph vessels and blood vessels based on the detection of near-infrared fluorescent light emitted from indocyanine green (ICG).
The new Lightvision system creates real-time contrast images of lymph vessels below tissue surfaces by:
